In re Androgel Antitrust Litigation (US District Court for the Northern District of Georgia)

We serve as liaison counsel for the direct purchaser plaintiffs in this multi-district litigation which alleges that the brand name manufacturer of the testosterone drug Androgel paid generic manufacturers to delay their entry into the market, allowing the brand name manufacturer to maintain its monopoly pricing. The case is consolidated with one brought by the Federal Trade.
« Back to Cases Index